Health Travere Therapeutics Announces FDA Accelerated Approval of FILSPARI™ (sparsentan), the First and… James Pereira Feb 18, 2023 <!-- Name:DistributionId Value:8752075 --> <!--… Read More...
Health Recent FDA Approval of Advanced Treatment for Patients with Metastatic Non Small-Cell Lung Cancer… James Pereira Dec 7, 2022 Ft. Myers, Fla., Dec. 06, 2022 (GLOBE NEWSWIRE) -- A clinical study conducted with participation by Florida Cancer… Read More...
Health FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in… James Pereira Jul 30, 2022 First and only topical PDE4 inhibitor approved for the treatment of plaque psoriasis, including intertriginous… Read More...
LifeStyle FDA Approves Sientra’s Low Plus Profile Projection Breast Implant Taner Halicioglu Jul 6, 2022 SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”)… Read More...
Health Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin,… James Pereira May 4, 2022 VOQUEZNA TRIPLE and DUAL PAKs each contain vonoprazan, a novel, first-in-class potassium-competitive acid blocker… Read More...
Health FDA Approved New Regimen for Patients With Melanoma James Pereira Mar 25, 2022 . Evan J. Lipson, MD, an associate professor of oncology at the Johns Hopkins Kimmel… Read More...